Multiepitope peptide‐loaded virus‐like particles as a vaccine against hepatitis B virus–related hepatocellular carcinoma
Fei‐Xiang Ding, Fang Wang, Yi‐Ming Lu, Ka Li, Kai‐Hui Wang, Xiao‐Wen He, Shu‐Han Sun – 27 April 2009 – To develop a hepatitis B virus (HBV) therapeutic vaccine that can induce a broad but specific immune response and significant antitumor effects both in vivo and in vitro, we inserted HBV X protein (HBx)‐derived epitopes HBx(52‐60), HBx(92‐100), and HBx(115‐123); a novel subdominant cytolytic T lymphocyte (CTL) epitope HBx(140‐148); and the universal T helper epitope pan human leukocyte antigen DR‐binding epitope into HBV core protein to form multiepitope peptide‐loaded virus‐like particles